126 related articles for article (PubMed ID: 9680896)
1. Oral manifestations of toxic epidermal necrolysis (TEN) in patients with AIDS: report of five cases.
Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
Oral Dis; 1998 Jun; 4(2):90-4. PubMed ID: 9680896
[TBL] [Abstract][Full Text] [Related]
2. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis.
Kimura S; Oka S; Mohri H; Mitamura K; Shimada K
Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215
[TBL] [Abstract][Full Text] [Related]
3. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
Raviglione MC; Dinan WA; Pablos-Mendez A; Palagiano A; Sabatini MT
Arch Intern Med; 1988 Dec; 148(12):2683-5. PubMed ID: 3264143
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
Navin TR; Miller KD; Satriale RF; Lobel HO
Lancet; 1985 Jun; 1(8441):1332. PubMed ID: 2860516
[No Abstract] [Full Text] [Related]
6. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
7. The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
Teira R; Virosta M; Muñoz J; Zubero Z; Santamaría JM
Scand J Infect Dis; 1997; 29(6):595-6. PubMed ID: 9580544
[TBL] [Abstract][Full Text] [Related]
8. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Pearson RD; Hewlett EL
Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis in a patient with AIDS.
Torresin A; Guida B; Piersantelli N; Massone L; Pestarino A
Clin Infect Dis; 1994 Aug; 19(2):358-9. PubMed ID: 7986923
[No Abstract] [Full Text] [Related]
11. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
Ugburo AO; Temiye EO; Ilombu CA
Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.
Saiag P; Caumes E; Chosidow O; Revuz J; Roujeau JC
J Am Acad Dermatol; 1992 Apr; 26(4):567-74. PubMed ID: 1597543
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
[TBL] [Abstract][Full Text] [Related]
14. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
[TBL] [Abstract][Full Text] [Related]
15. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection.
Azón-Masoliver A; Vilaplana J
Dermatology; 1993; 187(4):268-9. PubMed ID: 8274783
[TBL] [Abstract][Full Text] [Related]
17. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC
Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735
[TBL] [Abstract][Full Text] [Related]
18. HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital.
Tseng J; Maurer T; Mutizwa MM
J Int Assoc Provid AIDS Care; 2017; 16(1):37-41. PubMed ID: 26685211
[TBL] [Abstract][Full Text] [Related]
19. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Payen MC; De Wit S; Sommereijns B; Clumeck N
Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
